Atossa Therapeutics (ATOS) Intangibles (2011 - 2021)
Atossa Therapeutics (ATOS) posted quarterly Intangibles of $54000.0 for Q4 2021, up 31.71% year-over-year from $41000.0 in Q4 2020, and up 1111.31% quarter-over-quarter from $4458.0 in Q2 2021.
Atossa Therapeutics (ATOS) Intangibles (2011 - 2021) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Intangibles for 11 consecutive years, with $54000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Intangibles rose 31.71% year-over-year to $54000.0; the TTM figure through Dec 2021 stood at $54000.0 (up 31.71% YoY), while the FY2021 annual figure was $54000.0, up 31.71% from the prior year.
- Intangibles advanced to $54000.0 in Q4 2021 per ATOS's latest filing, from $4458.0 in the prior quarter.
- Across five years, Intangibles topped out at $752540.0 in Q1 2017 and bottomed at $4458.0 in Q2 2021.
- Historically, Intangibles has averaged $144336.2 across 5 years, with a median of $68542.0 in 2019.
- Annual changes were most pronounced in 2019 — Intangibles soared 38.37% — and 2021, when it tumbled 91.61%.
- Atossa Therapeutics' Intangibles stood at $234000.0 in 2017, then slipped by 17.95% to $192000.0 in 2018, then tumbled by 64.3% to $68542.0 in 2019, then tumbled by 40.18% to $41000.0 in 2020, then soared by 31.71% to $54000.0 in 2021.
- Business Quant data shows ATOS's Intangibles at $54000.0 in Q4 2021, $4458.0 in Q2 2021, and $8917.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 54,000.00 |
| Jun 30, 2021 | 4,458.00 |
| Mar 31, 2021 | 8,917.00 |
| Dec 31, 2020 | 41,000.00 |
| Sep 30, 2020 | 45,417.00 |
| Jun 30, 2020 | 53,125.00 |
| Mar 31, 2020 | 60,833.00 |
| Dec 31, 2019 | 68,542.00 |
| Sep 30, 2019 | 76,250.00 |
| Jun 30, 2019 | 83,958.00 |
| Mar 31, 2019 | 91,667.00 |
| Dec 31, 2018 | 192,000.00 |
| Sep 30, 2018 | 55,107.00 |
| Mar 31, 2018 | 70,547.00 |
| Dec 31, 2017 | 234,000.00 |
| Sep 30, 2017 | 561,354.00 |
| Mar 31, 2017 | 752,540.00 |
| Sep 30, 2016 | 1.40 Mn |
| Jun 30, 2016 | 1.45 Mn |
| Mar 31, 2016 | 639,000.00 |